FilingReader Intelligence

Huahai Pharmaceutical to host Q3 2025 earnings briefing

November 10, 2025 at 09:21 AM UTCBy FilingReader AI

Zhejiang Huahai Pharmaceutical Co., Ltd. will host its 2025 third-quarter earnings briefing on Tuesday, November 18, 2025, from 15:00 to 16:00. The online event, held via the Shanghai Stock Exchange Roadshow Center, will allow investors to engage with the company regarding its operational results and financial metrics for the period.

The briefing follows the release of the company's 2025 third-quarter report on October 31, 2025. Attendees will have the opportunity to interact with key management, including Chen Baohua (chairman and president), Zhu Yonghua (director, vice president, and board secretary), Zhang Mei (senior vice president and CFO), and Deng Chuan (independent director).

Investors can submit questions in advance from November 11, 2025, to 16:00 on November 17, 2025, through the "Question Pre-collection" section on the SSE Roadshow Center website or by emailing 600521@huahaipharm.com. The company will address commonly raised questions during the interactive session. After the event, a recording and key content will be available on the SSE Roadshow Center.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:600521Shanghai Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →